Literature DB >> 20150852

The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus.

I Alper1, S Ulukaya, O Makay, T Balcioglu.   

Abstract

AIM: The aim of this prospective study was to investigate whether the neuromuscular response to rocuronium is affected by the presence of type 2 diabetes mellitus.
METHODS: Neuromuscular functions were measured after the administration of 0.6 mg/kg rocuronium with train-of-four stimulations in patients with type 2 diabetes mellitus (DM, N=14) and without diabetes mellitus (control, N=14) during isoflurane based general anesthesia. The onset time, clinical duration and recovery index of rocuronium were compared in the two groups.
RESULTS: The mean onset time (136 +/- 40 vs 118 +/- 20 s), clinical duration (51 +/- 11 vs 48 +/- 11 min) and recovery index (6.0 +/- 2.5 vs 5.9 +/- 1.4 min) of the neuromuscular block were not significantly different between the DM and control groups, respectively (p>0.05).
CONCLUSIONS: The present study has proven that the rocuronium-induced neuromuscular block was not affected in patients with type 2 diabetes mellitus during isoflurane based general anesthesia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20150852

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

Review 1.  [Aspects of perioperative care in patients with diabetes].

Authors:  G Pestel; D Closhen; A Zimmermann; C Werner; M M Weber
Journal:  Anaesthesist       Date:  2013-01       Impact factor: 1.041

2.  Streptozotocin diabetes attenuates the effects of nondepolarizing neuromuscular relaxants on rat muscles.

Authors:  Lina Huang; Dan Chen; Shitong Li
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.